Medpace General Counsel & Corp. Secy. Sold Shares Worth Over $859K
Medpace Holdings' General Counsel Stephen P. Ewald sold 1,245 shares at $690 each, totaling $859,050. He now directly owns 19,098 shares, according to an SEC Form 4 filing.
How this was made

The 30-second read
Why it matters
The disclosed sale reduces insider ownership, which can be interpreted as a slight negative signal.
Market read
Small insider sell; limited immediate market impact.
What to watch
Potential tax planning or personal liquidity needs driving the sale.
Background
Form 4 insider transaction disclosures provide transparency on executive holdings.
Market effects
None significant for the broader healthcare services sector.
Limited to US markets where Medpace trades.
Minimal.
Counterpoint
The sale could be unrelated to company fundamentals and may not affect price.
Key entities
- CompanyMedpace Holdings, Inc.
US-listed clinical research organization (NASDAQ: MPC).
- ExecutiveStephen P. Ewald
General Counsel & Corporate Secretary of Medpace.


